Liangliang Li Chongyang Wu Ye Chai Chi Dong Li Zhao
10.1177/20587384211009342
Int J Immunopathol Pharmacol
2021 Jan-Dec;35:20587384211009342.
chidamide histone deacetylase inhibitor long-term remission subcutaneous panniculitis-like t-cell lymphoma
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/33845613/
Aminopyridines / therapeutic use Benzamides / therapeutic use Histone Deacetylase Inhibitors / therapeutic use Lymphoma, T-Cell / drug therapy Panniculitis / drug therapy
Aminopyridines / therapeutic use Benzamides / therapeutic use Histone Deacetylase Inhibitors / therapeutic use Lymphoma, T-Cell / drug therapy Panniculitis / drug therapy Case Reports Review Antineoplastic Combined Chemotherapy Protocols / therapeutic use Cyclophosphamide / therapeutic use Doxorubicin / therapeutic use Etoposide / therapeutic use Female Humans Middle Aged Prednisone / therapeutic use Remission Induction Vincristine / therapeutic use Aminopyridines Benzamides Histone Deacetylase Inhibitors Vincristine Etoposide Doxorubicin N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide Cyclophosphamide Prednisone EPOCH protocol Subcutaneous panniculitis-like T-cell lymphoma
PMC8059039
33845613
Chidamide induces long-term remission in rare subcutaneous panniculitis-like T-cell lymphoma: An unusual case report and literature review
2021